Smart Capital Traders
  • Politics
  • Investing
  • Latest News
  • Stocks

Smart Capital Traders

  • Politics
  • Investing
  • Latest News
  • Stocks
Politics

Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

by admin April 16, 2025
April 16, 2025
Top Hegseth advisor Dan Caldwell placed on administrative leave by Defense Department

A top advisor to Defense Secretary Pete Hegseth was escorted out of the Pentagon on Tuesday and placed on administrative leave, according to a Defense Department official. 

Reuters first reported Caldwell had been placed on leave for an ‘unauthorized disclosure’ of information amid an investigation into Pentagon leaks. An official confirmed to Fox News Digital that Reuters’ reporting is accurate but declined to comment on an ongoing investigation. 

Caldwell previously worked at restraint-minded think tank Defense Priorities and Concerned Veterans for America, a group formerly led by Hegseth. A foreign policy realist, he has argued that the U.S. should dramatically reduce its footprint in Europe and pull out forces in Iraq and Syria. 

Last month, the Defense Department announced a probe into ‘recent unauthorized disclosures of national security information’ and said it planned to use polygraphs to determine the source of leaks. 

‘The use of polygraphs in the execution of this investigation will be in accordance with applicable law and policy,’ DOD Chief of Staff Joe Kasper wrote in a memo. ‘This investigation will commence immediately and culminate in a report to the Secretary of Defense.’

He wrote that ‘information identifying a party responsible for an unauthorized disclosure’ would be referred for criminal prosecution.

Caldwell did not immediately reply to a request for comment. 

Caldwell’s closeness to the defense secretary was underscored in the unintentionally leaked Signal chat on Houthi strikes, where Hegseth named him as the Pentagon point of contact for the offensive campaign. 

This post appeared first on FOX NEWS

previous post
Soaring Medicare prescription drug prices targeted in Trump’s new executive order
next post
Schumer calls on Leland Dudek, acting commissioner of SSA, to resign

related articles

Trump doubles down on voiding Biden autopen actions,...

December 3, 2025

Biden finalizes crackdown on US military tech investments...

October 31, 2024

Bush DOJ lawyer warns Trump admin against ‘terrible...

March 23, 2025

Jim Caviezel starring in Bolsonaro biopic as son...

December 10, 2025

How AI browsers open the door to new...

September 21, 2025

Clintons agree to testify after House threatens contempt...

February 3, 2026

VP Vance blasts McConnell’s vote against Trump Pentagon...

April 9, 2025

New US military GenAI tool ‘critical first step’...

December 24, 2025

Family matters: How VP Vance, wife deliver ‘normalcy...

May 4, 2025

Trump dispels rumors he will seek to ban...

December 17, 2024

    Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.


    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Most Popular

    • 1

      Environmental Approval for Boland Infield Studies & Update on Scaled Column ISR Test

      September 19, 2025
    • 2

      Bold Ventures Announces Final Closing of Non-Brokered Private Placement and Insider Subscriptions

      October 19, 2024
    • 3

      Retraction of Forecast Financial Information Plus Announcement on New Metallurgical Testwork Results

      October 15, 2024
    • 4

      Emyria and UWA in Partnership to Commercialise Novel Serotonin-Releasing Agents for Mental Health and Neurology

      October 31, 2024
    • 5

      As North Korea, Iran and China support Russia’s war, is a ‘new axis’ emerging?

      October 25, 2024

    Categories

    • Investing (3,716)
    • Latest News (2,300)
    • Politics (4,600)
    • Stocks (1,442)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: smartcapitaltraders.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 smartcapitaltraders.com | All Rights Reserved